Carcinoma Prostate Clinical Trial
Official title:
A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.
Open label, single arm, phase II multicentre study designed to determine the clinical benefit, as measured by 3-months disease control rate (DCR) provided by enzalutamide in metastatic Castration Resistant Prostate Cancer patients with at least one visceral site involvement.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03323879 -
Combined LDR Boost and HDR Whole Gland
|
Phase 1/Phase 2 | |
Recruiting |
NCT05265988 -
Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib
|
Phase 2 | |
Completed |
NCT01939743 -
Efficacy of Diclofenac Suppository for Pain Control in Ultrasound Guided Biopsy of Prostate
|
Phase 2 | |
Not yet recruiting |
NCT04985357 -
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs
|